Wednesday, September 20, 2017 2:12:41 PM
It's a tough one... I'm still sitting on the last round of buys when CG's was still in the picture. Not sure if I should be buying more or hold off until something is released and jump on the ride at that point. Sal has been quiet for two weeks now. I sent him a message on LinkedIn just asking him if he could confirm his role as Director of Ops within UHLN, and he did not respond, even though it shows you that he read it. Same thing with Twitter... he's never responded, but I can see he's read it. It's mildly frustrating that you can't even get a confirmation of what was put out in a PR prior. His linkedin just states that he is a consultant, but not linked to UHLN.
If I bought in now, I'd be averaging down, but it's still a pretty high risk considering the silence.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM